Justine Dellaringa
Senior Director Translational Research @Bristol Myers Squibb
Signup · Get unlimited contacts
WORK HISTORY
Senior Director Translational Research @Bristol Myers Squibb
US
Co-lead the Cell Therapy Translational Research organization, shaping strategy and execution across early and late-stage programs in oncology and autoimmunity, including 31 clinical trials and 25+ regulatory submissions.• Lead the Translational Research Technology, Operations, and Cell Therapy Safety team, overseeing a multidisciplinary group of subject matter experts in cytometry, genomics, spatial biology, and proteomics supporting investigational and commercial programs including Abecma and Breyanzi.• Established and implemented a novel safety testing algorithm to investigate CAR T cell product involvement in secondary malignancies, aligning with global health authority guidance and enabling consistent interpretation and reporting across 5 investigational cell therapy assets,>18 clinical studies and 2 commercial assets.• Directed the development and clinical implementation of innovative assays—including real-time pharmacodynamic assays, spatial biomarker panels, high dimensional cytometry, and molecular assessments—to support mechanistic insights, dose selection, and regulatory filings across gene-edited assets.• Sponsored creation of centralized dashboards and automated workflows for real-time monitoring of CAR T persistence, signal detection, and integration site analysis (ISA), ensuring regulatory compliance and rapid decision-making.• Championed translational safety strategy across the cell therapy portfolio, leading cross-functional alignment on data interpretation, reporting, and health authority interactions for both investigational and marketed products.• Serve as a core member of the Translational Advisory Forum, guiding biomarker implementation strategy, assay readiness, and translational investment decisions across the cell therapy pipeline.• Lead translational safety assessments for cell therapy programs including cross portfolio strategy alignment, implementation and outcome reporting for regulatory compliance.
EDUCATION
Illinois State University
Bachelor of Science (B.S.), Biology, General
SKILLS
ABOUT JUSTINE DELLARINGA
Experienced and passionate scientific leader with over 25 years of driving innovation in translational research across immuno-oncology and cell therapy. I lead multidisciplinary teams in developing and implementing biomarker strategies, novel assays, and real-time safety testing to support clinical development from first-in-human through commercialization. My work has contributed to the approval and lifecycle management of transformative therapies like Abecma and Breyanzi, while advancing next-generation therapies through data-driven insights.I have a strong track record of strategic leadership, operational excellence, and cross-functional collaboration—delivering high-quality, decision-enabling data across more than 30 clinical trials and 25 regulatory submissions. As a co-leader of the Cell Therapy Translational Research organization, I thrive on building partnerships that bridge discovery, development, and regulatory functions. I’m deeply motivated by the opportunity to translate complex science into meaningful outcomes for patients and to empower teams to deliver their best work in pursuit of that mission
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.